secwatch.observer — SEC 8-K summary
======================================

Issuer:     INNOVATE Corp. (VATE)
CIK:        0001006837
Form:       8-K
Filed at:   2026-05-14T20:11:26+00:00
Accession:  0001006837-26-000038
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INNOVATE Q1 revenue up 33% to $364.8M; net loss narrows to $17.2M; adjusted EBITDA rises 174% to $19.7M
--------------------------------------------------------------------------------

- Infrastructure segment revenue $357.9M (+35.1% YoY); DBMG reported backlog $1.6B, adjusted backlog $1.8B.
- Life Sciences: MediBeacon received CE mark under EU MDR for Transdermal GFR Monitor and Reusable Sensor.
- Spectrum revenue $5.3M (down 14.5% YoY) on advertising softness; collaborative trials underway with major carrier.
- Net loss per diluted share improved to ($1.29) from ($1.89) YoY; Total Adjusted EBITDA $19.7M vs $7.2M.
- Cash and cash equivalents $134.6M at March 31, 2026; non-operating corporate cash $2.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006837/000100683726000038/0001006837-26-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006837/000100683726000038/vate-20260514.htm
  HTML page:      https://secwatch.observer/filing/0001006837-26-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer